Natus Medical Announces 2010 Third Quarter EPS of $.17
October 28, 2010 7:23 AM
Natus Medical Incorporated (Nasdaq: BABY) today announced financial results for the three and nine months ended September 30, 2010.
For the third quarter ended September 30, 2010, Natus reported revenue of $53.3 million, compared to $44.3 million reported in the comparable quarter of the previous year. Net income was $3.7 million, or $0.13 per diluted share, for the third quarter of both 2010 and 2009.
On a non-GAAP basis the Company reported net income $4.9 million, or $0.17 per diluted share, for the third quarter of 2010, compared with net income of $4.1 million, or $0.14 per diluted share, for the third quarter of 2009.
The non-GAAP results for the third quarter of 2010 exclude $1.2 million of amortization expense associated with acquisition-related intangible assets, a charge of $323,000 associated with the discontinuance of the Clarity newborn hearing screening product line, and $179,000 of direct costs incurred in the third quarter associated with the Company's acquisition of Medix on October 12, 2010.
